Fredun Pharmaceuticals Ltd Q2FY22 PAT soars to Rs. 1.83 crore

Fredun Pharmaceuticals Ltd has reported Standalone financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 54.7624 crores during the period ended September 30, 2021 as compared to Rs. 45.2494 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 1.8397 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 0.3283 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 4.61 for the period ended September 30, 2021 as compared to Rs. 0.82 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 54.7624 crs	₹45.2494 crs	21.02%
Net Profit	₹1.8397 crs	₹0.3283 crs	460.37%
EPS	₹4.61	₹0.82	462.20%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 54.7624 crores during the period ended September 30, 2021 as compared to Rs.33.5997 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.1.8397 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.0.8265 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.4.61 for the period ended September 30, 2021 as compared to Rs.2.07 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 54.7624 crs	₹33.5997 crs	62.98%
Net Profit	₹1.8397 crs	₹0.8265 crs	122.59%
EPS	₹4.61	₹2.07	122.71%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.100.0118 crores during the 6 Months period ended September 30, 2021 as compared to Rs.47.3424 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.2.1680 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.0.8627 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.5.43 for the 6 Months period ended September 30, 2021 as compared to Rs.2.16 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹100.0118 crs	₹47.3424 crs	111.25%
Net Profit	₹2.1680 crs	₹0.8627 crs	151.30%
EPS	₹5.43	₹2.16	151.39%

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 506.40 as compared to the previous close of Rs. 506.65. The total number of shares traded during the day was 2070 in over 106 trades.

The stock hit an intraday high of Rs. 519.00 and intraday low of 490.00. The net turnover during the day was Rs. 1050086.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals Q2FY22 H1FY22 ResultUpdate